glp-1 and gout Drugs May Raise the Risk of Osteoporosis Gout, Study Suggests Weight Reduction with GLP-1 Agonists

For a long time, this medication was the only drug of its type, but in recent years, other GLP-1 agonists have been approved for both the treatment of diabetes and the treatment of obesity

Unlike earlier compounds that target one or two pathways, Retatrutide was designed to influence multiple metabolic mechanisms at the same time

Filling the Syringe Uncap your insulin syringe but be careful, theyre tiny little needles

Glucagon-Like Peptide 1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus. Edited by David M Nathan and Katya Rubinow, UpToDate, Wolters Kluwer, 9 Nov

Retatrutide targets three different receptors: GLP-1 (helps regulate appetite and blood sugar) GIP (supports insulin response) Glucagon (affects energy use and fat metabolism) By targeting all three, the medication delays how fast your stomach digests food, lowers your appetite, and ultimately reduces how much food you eat

These functions help manage blood sugar levels and can aid in weight loss